More genes associated with an increased risk of triple-negative breast cancer have been identified by researchers.
Surviving breast cancer is certainly its own reward, but a new study finds that many who do are saddled with thousands in out-of-pocket expenses for years.
The widely used chemotherapy drug trastuzumab (Herceptin) can be life-saving for women with HER2-positive breast cancer, a particularly aggressive form of the disease.
For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an experimental drug could improve survival, a new study suggests.
For women who have their breast removed while fighting cancer, using their own tissue for breast reconstruction is better than implants, a new study suggests.
